# A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Polyps

> **NCT06454240** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 79 (actual)

## Conditions studied

- Chronic Rhinosinusitis With Nasal Polyps

## Interventions

- **DRUG:** lunsekimig
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT06454240
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-17
- **Primary completion:** 2026-01-29
- **Final completion:** 2026-04-23
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06454240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06454240, "A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Polyps". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06454240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*